Conference homeSessions
Join researchers, clinicians, and industry experts for a full scientific program covering psychedelic-assisted therapy, AI in psychiatry, opioid crisis solutions, GLP-1 addiction research, and precision mental health care—through keynote talks, expert panels, poster sessions, and workshops.
See how AI, machine learning, and digital therapeutic platforms are transforming psychiatric diagnostics, behavioral pattern recognition, and clinical decision-making — making mental health care smarter and faster.
The most urgent advances in opioid use disorder management, fentanyl overdose prevention, medication-assisted treatment protocols, and harm reduction strategies are among the most critical public health priorities today.
Fast-growing clinical evidence behind psilocybin, ketamine, and MDMA-assisted therapies for treatment-resistant depression, PTSD, addiction, and anxiety—plus the regulatory landscape shaping their future.
Groundbreaking research on GLP-1 receptor agonists — including semaglutide and tirzepatide — and their potential to reduce alcohol cravings, substance use behaviors, and compulsive disorders, reshaping addiction pharmacotherapy.
The latest clinical strategies for treating patients with co-occurring substance use disorders and psychiatric conditions — including depression, bipolar disorder, schizophrenia, and PTSD — and the integrated care models delivering the best outcomes.
Growing understanding of neural reward pathways, genetic vulnerability, neuroplasticity, and molecular mechanisms driving addiction — and the next-generation biological therapies changing how we treat substance use and psychiatric disorders.
The powerful links between childhood trauma, adverse experiences, PTSD, and addiction — and the latest evidence-based trauma-informed care models, somatic therapies, and integrated treatment approaches improving recovery outcomes.
How genomic profiling, biomarker-driven diagnostics, and personalized pharmacogenomic strategies are helping clinicians tailor psychiatric and addiction treatment to each patient's unique biology—from treatment-resistant depression to opioid use disorder.
The list of topics covers current and future research in addiction medicine, psychiatry, behavioral health, and mental health recovery: advancing evidence-based treatment.
Program sessions include presentations, poster sessions, and workshops, which together foster knowledge exchange, discussion, and collaboration.
Thought leaders in addiction medicine and psychiatry present transformative insights shaping the future of mental health, recovery, and behavioral health care worldwide.
Peer-reviewed addiction medicine and psychiatry research delivered in focused clinical tracks and specialty behavioral health sessions.
Dedicated viewing periods with researchers and clinicians available for interactive dialogue and mental health research networking.
Expert exchanges on clinical protocols, psychiatric guideline updates, recovery policy, and evidence-based management of substance use and mental health disorders.
Hands-on sessions covering clinical interviewing skills, CBT and DBT techniques, motivational interviewing practice, psychopharmacology case reviews, and risk assessment protocols.
Mentored presentations by early-career psychiatrists, addiction medicine fellows, and behavioral health researchers exploring innovative directions in mental health and recovery science.
Visit NAPC-2027 in San Diego, California and connect with leading psychiatrists, addiction medicine specialists, behavioral health counselors, and recovery advocates advancing mental health and addiction care worldwide.
